1. EPWORTH Knowedge Bank
  2. Academic & Clinical
  3. Cancer Services
Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/231
Full metadata record
DC FieldValueLanguage
dc.contributor.authorO'Sullivan, Richarden
dc.contributor.otherChang, Joeen
dc.contributor.otherLim Loon, Darylen
dc.contributor.otherDavis, Ianen
dc.contributor.otherLee, Sze Tingen
dc.contributor.otherHiew, Chee Yanen
dc.contributor.otherEsler, Stephenen
dc.contributor.otherGong, Sylviaen
dc.contributor.otherWada, Morikatsuen
dc.contributor.otherClouston, Daviden
dc.contributor.otherGoh, Yinen
dc.contributor.otherBolton, Damienen
dc.contributor.otherScott, Andrewen
dc.contributor.otherKhoo, Vincenten
dc.date2015-04-08en
dc.date.accessioned2015-06-11T04:11:47Zen
dc.date.available2015-06-11T04:11:47Zen
dc.date.issued2015-06en
dc.identifier.citationInt J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):438-45.en
dc.identifier.issn0360-3016en
dc.identifier.urihttp://hdl.handle.net/11434/231en
dc.description.abstractNovel imaging modalities can be used to define targets within the prostate to guide focal therapies, which can theoretically improve the therapeutic ratio compared to conventional whole-gland therapies. We used histopathological reference standards to compare [11C]choline positron emission tomography (PET) with magnetic resonance imaging (MRI) for delineating malignant intraprostatic lesions for guiding focal therapies. [11C]choline PET was found to be significantly more accurate than MRI.en
dc.publisherElsevieren
dc.subjectImaging Modalitiesen
dc.subjectProstateen
dc.subjectFocal Therapiesen
dc.subject[11C]choline positron emission tomographyen
dc.subjectPETen
dc.subjectMagnetic Resonance Imagingen
dc.subjectMRIen
dc.subjectMalignant Intraprostatic Lesionsen
dc.subjectProstate Adenocarcinomaen
dc.subjectRadical Prostatectomyen
dc.subjectHealthcare Imaging, Epworth Hospital, Victoria, Australiaen
dc.subjectHealthcare Imaging, Epworth Hospital, Victoria, Australia-
dc.titleComparison of [11C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic Lesionsen
dc.typeJournal Articleen
dc.identifier.doi10.1016/j.ijrobp.2015.02.004en
dc.identifier.journaltitleInternational Journal of Radiation Oncology, Biology, Physicsen
dc.description.pubmedurihttp://www.ncbi.nlm.nih.gov/pubmed/25864171en
dc.description.affiliatesRadiation Oncology Centre, Austin Health, Victoria, Australiaen
dc.description.affiliatesThe University of Melbourne, Melbourne, Victoria, Australiaen
dc.description.affiliatesMonash University Eastern Health Clinical School, Victoria, Australiaen
dc.description.affiliatesCentre for PET, Austin Health, Victoria, Australiaen
dc.description.affiliatesLudwig Institute for Cancer Research, Victoria, Australiaen
dc.description.affiliatesDepartment of Radiology, Austin Health, Victoria, Australiaen
dc.description.affiliatesTissupath, Mt Waverley, Victoria, Australiaen
dc.description.affiliatesDiagnostic Imaging, Monash Health, Victoria, Australiaen
dc.description.affiliatesDepartment of Urology, Austin Health, Victoria, Australiaen
dc.description.affiliatesRoyal Marsden Hospital, National Health Service Foundation Trust, London, United Kingdomen
dc.type.studyortrialCohort Studyen
dc.type.contenttypeTexten
Appears in Collections:Cancer Services
Radiation Oncology

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.